Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
DRUG MRZ-112 - Phast 1B, Multicenter, Open-Label Study of Marizomib Combined with Temozolomide and Radiotherapy in Ptients with Newly Diagnosed who Grade IV Malignant Glioma
Stupp, Roger
(PD/PI)
Neurological Surgery
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/25/17
→
9/25/20
Funding
Triphase Accelerator US Corp.
(DRUG MRZ-112)
Celgene International II Sàrl
(DRUG MRZ-112)
View all
View less